Cancer Research UK logo.
SearchDonate
  • Search

A study looking for proteins that can show how well chemotherapy has worked after surgery for pancreatic cancer (ESPAC-Tplus)

Overview

Cancer types:

Pancreatic cancer

Status:

Results

Phase:

Other

Details

This study is trying to find proteins in pancreatic cancer tissue that could help doctors tell how well chemotherapy will work for people in the future.

This study is linked to the ESPAC trials, and is looking at samples from people who have taken part in either ESPAC-1, ESPAC-3 (v2) or ESPAC-4. These results are from people who took part in the ESPAC- 3 (v2) trial.

Cancer Research UK supported this study.

Recruitment start: 1 December 2007

Recruitment end: 21 November 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor John Neoptolemos

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Royal Liverpool and Broadgreen University Hospital NHS Trust

University of Liverpool

Last reviewed: 29 Jun 2016

CRUK internal database number: 2131

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.